Cited by 47Advanced Glycation End Products researchAngiogenesis and VEGF in CancerRetinal Diseases and Treatments

Advanced Glycation End Products Induce Angiogenesis in Vivo

Okamoto, Tamami, Tanaka, Shinya, Stan, Alex C., Koike, Takao, Kase, Manabu, Makita, Zenji, Sawa, Hirofumi, Nagashima, Kazuo·2002·Microvascular Research

Abstract

Advanced glycation end products (AGEs) have been thought to participate in diabetic microangiopathy. However, the effects of AGEs on angiogenesis have so far been mainly examined either in vitro or by using cultured cells. In the present study, we have analyzed whether AGEs induce angiogenesis in vivo by using the chorioallantoic membrane (CAM) assay. The CAM assay was carried out in embryonated hen eggs to determine the effects of AGEs. Following generation of AGEs based on bovine serum albumin (BSA), either AGE-BSA or nonglycated BSA was administered to the CAM and their effects on angiogenesis were assessed, together with an inhibitory effect of an anti-AGE antibody against AGE-BSA-induced angiogenesis. The histological features of AGE-induced vascular lumens were examined by immunohistochemical analysis for Factor VIII and smooth muscle alpha-actin. AGE-BSA induced angiogenesis in CAM in a dose- and time-dependent manner. AGE-induced angiogenesis on CAM was neutralized by the anti-AGE antibody. Immunohistochemical analysis demonstrated that AGE-induced vascular lumens were devoid of pericytes. Our data demonstrated that AGEs are an angiogenetic factor and that our system of AGE-induced abnormal vessels in CAMs is useful in further investigations of the mechanism of diabetic retinal angiogenesis and can also be used to provide a therapeutic model for diabetic angiopathy.

Integrity signals

Registry

Crossref · 10.1006/mvre.2001.2371

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Okamoto, T., Tanaka, S., Stan, A. C., Koike, T., Kase, M., Makita, Z., Sawa, H., & Nagashima, K.
Affiliations
  • Hokkaido University (JP)
  • Medizinische Hochschule Hannover (DE)
  • Teine Keijinkai Hospital (JP)
  • Kurume University (JP)
Venue
Microvascular Research
Publisher
Elsevier BV
Published
2002-03
Volume
63
Issue
2
Pages
186-195
ISSN
0026-2862 (ISSN-L)
OpenAlex
W2006104786
Cited by
47
References
33
Citations by year
2022: 2 · 2020: 1 · 2018: 2 · 2017: 3 · 2014: 2 · 2012: 3
FWCI
3.71
Type
journal article
Language
en
Open access
closed
Locations
  • Microvascular Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
advanced glycation end products, angiogenesis, diabetic microangiopathy, chorioallantoic membrane assay, bovine serum albumin, pericytes
MeSH terms
Animals, Chick Embryo, Chorion, Dose-Response Relationship, Drug, Humans, Immunohistochemistry, Lymphokines, Neovascularization, Pathologic, Recombinant Proteins, Time Factors, Linear Models, Endothelial Growth Factors, Glycation End Products, Advanced, Fractals, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review